[The role of polychemotherapy in the management of malignant bone tumors]

Chirurg. 2002 Dec;73(12):1170-3. doi: 10.1007/s00104-002-0555-9.
[Article in German]

Abstract

Osteosarcoma,chondrosarcoma and Ewing tumors are the most common primary malignant bone tumors. Due to early hematogenous dissemination, surgery alone is able to cure less than 20% of patients with osteosarcoma. In Ewing-tumors less than 10% of patients will be cured with local treatment alone. By the use of aggressive polychemotherapy, given both pre- and post-surgery, cure rates of more than 50% for Ewing-tumors and about 70% for osteosarcoma could be achieved.Thus,chemotherapy is an indispensable part of the multimodal treatment of these tumor types. Chondrosarcomas are usually more highly differentiated and therefore show a lower rate of metastasis. The use of chemotherapy is not established in these tumors.

Publication types

  • English Abstract

MeSH terms

  • Adolescent
  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Bone Neoplasms / drug therapy*
  • Bone Neoplasms / mortality
  • Bone Neoplasms / surgery*
  • Chemotherapy, Adjuvant
  • Child
  • Chondrosarcoma / drug therapy*
  • Chondrosarcoma / surgery*
  • Clinical Trials as Topic
  • Combined Modality Therapy
  • Female
  • Histiocytoma, Benign Fibrous / drug therapy*
  • Histiocytoma, Benign Fibrous / mortality
  • Histiocytoma, Benign Fibrous / surgery*
  • Humans
  • Male
  • Neoplasm Metastasis
  • Osteosarcoma / drug therapy*
  • Osteosarcoma / surgery*
  • Postoperative Care
  • Preoperative Care
  • Prognosis
  • Randomized Controlled Trials as Topic
  • Sarcoma, Ewing / drug therapy*
  • Sarcoma, Ewing / surgery*
  • Time Factors